CA Stock MarketDetailed Quotes

APLI Appili Therapeutics Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Oct 3 16:00 ET
3.03MMarket Cap-833P/E (TTM)

Appili Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
0
147.60%827.41K
-96.50%11.7K
478.4K
337.31K
0
-75.97%334.18K
334.18K
0
0
Operating revenue
--0
147.60%827.41K
-96.50%11.7K
--478.4K
--337.31K
--0
-75.97%334.18K
--334.18K
--0
--0
Cost of revenue
Gross profit
Operating expense
-77.29%297.1K
-63.13%2.99M
-76.58%597.46K
-86.16%328.91K
-35.67%755.34K
-34.86%1.31M
-67.57%8.11M
16.59%2.55M
-46.22%2.38M
-89.38%1.17M
Selling and administrative expenses
-18.03%764.55K
-31.35%3.05M
-21.57%817.49K
-60.36%564.71K
-18.16%732.23K
-13.41%932.71K
-3.77%4.44M
-5.82%1.04M
15.09%1.42M
-20.81%894.67K
-General and administrative expense
-18.03%764.55K
-31.35%3.05M
-21.57%817.49K
-60.36%564.71K
-18.16%732.23K
-13.41%932.71K
-3.77%4.44M
-5.82%1.04M
15.09%1.42M
-20.81%894.67K
Research and development costs
55.61%2.02M
53.04%5.83M
5.71%1.61M
83.55%1.83M
262.26%1.09M
31.59%1.3M
-82.24%3.81M
14.02%1.52M
-70.78%998.81K
-97.06%300.3K
Other operating expenses
-169.66%-2.49M
-4,151.87%-5.89M
-11,636.72%-1.83M
-4,317.41%-2.07M
-5,019.14%-1.06M
-1,570.55%-922.58K
86.97%-138.47K
93.90%-15.6K
80.19%-46.84K
93.02%-20.8K
Operating profit
77.29%-297.1K
72.19%-2.16M
73.57%-585.76K
106.29%149.49K
64.40%-418.03K
34.86%-1.31M
67.07%-7.78M
-1.32%-2.22M
21.52%-2.38M
89.38%-1.17M
Net non-operating interest income (expenses)
-230.09%-1.23M
-51.40%-1.61M
13.81%-382.36K
-64.60%-433.05K
-122.63%-425.83K
-121.71%-372.96K
29.91%-1.07M
61.27%-443.63K
-11.42%-263.08K
-45.74%-191.27K
Non-operating interest income
--0
-43.74%16.81K
-91.50%562
-40.34%5.58K
-74.19%2.35K
72.01%8.33K
-11.41%29.88K
20.83%6.61K
36.98%9.35K
84.02%9.09K
Non-operating interest expense
222.88%1.23M
48.80%1.63M
-14.95%382.92K
61.00%438.62K
113.71%428.18K
120.32%381.29K
-29.51%1.1M
-60.88%450.24K
12.14%272.43K
47.12%200.36K
Other net income (expenses)
-139.01%-56.71K
118.01%65.66K
-2,109.62%-126.39K
152.20%137.31K
68.52%-90.66K
205.83%145.39K
-741.72%-364.61K
1,064.57%6.29K
56.67%54.44K
-2,032.45%-287.95K
Gain on sale of security
-139.01%-56.71K
118.01%65.66K
-2,109.62%-126.39K
152.20%137.31K
68.52%-90.66K
205.83%145.39K
-741.72%-364.61K
1,064.57%6.29K
56.67%54.44K
-2,032.45%-287.95K
Income before tax
-3.18%-1.58M
59.69%-3.71M
58.76%-1.09M
94.34%-146.25K
43.48%-934.52K
33.62%-1.54M
63.29%-9.21M
20.40%-2.65M
19.96%-2.59M
85.20%-1.65M
Income tax
0
91.20%69.58K
30.28%8.96K
-82.16%6.09K
376.91%42.04K
18.35%12.5K
-5.37%36.39K
1,764.65%6.88K
268.09%34.13K
-278.58%-15.18K
Earnings from equity interest net of tax
Net income
-2.35%-1.58M
59.09%-3.78M
58.53%-1.1M
94.18%-152.34K
40.39%-976.56K
33.39%-1.55M
63.20%-9.24M
20.18%-2.66M
19.13%-2.62M
85.34%-1.64M
Net income continuous operations
-2.35%-1.58M
59.09%-3.78M
58.53%-1.1M
94.18%-152.34K
40.39%-976.56K
33.39%-1.55M
63.20%-9.24M
20.18%-2.66M
19.13%-2.62M
85.34%-1.64M
Noncontrolling interests
Net income attributable to the company
-2.35%-1.58M
59.09%-3.78M
58.53%-1.1M
94.18%-152.34K
40.39%-976.56K
33.39%-1.55M
63.20%-9.24M
20.18%-2.66M
19.13%-2.62M
85.34%-1.64M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-2.35%-1.58M
59.09%-3.78M
58.53%-1.1M
94.18%-152.34K
40.39%-976.56K
33.39%-1.55M
63.20%-9.24M
20.18%-2.66M
19.13%-2.62M
85.34%-1.64M
Diluted earnings per share
0.00%-0.01
62.50%-0.03
50.00%-0.01
93.72%-0.0013
0.00%-0.01
66.67%-0.01
78.95%-0.08
60.00%-0.02
60.00%-0.02
94.44%-0.01
Basic earnings per share
0.00%-0.01
62.50%-0.03
50.00%-0.01
93.72%-0.0013
0.00%-0.01
66.67%-0.01
78.95%-0.08
60.00%-0.02
60.00%-0.02
94.44%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 0147.60%827.41K-96.50%11.7K478.4K337.31K0-75.97%334.18K334.18K00
Operating revenue --0147.60%827.41K-96.50%11.7K--478.4K--337.31K--0-75.97%334.18K--334.18K--0--0
Cost of revenue
Gross profit
Operating expense -77.29%297.1K-63.13%2.99M-76.58%597.46K-86.16%328.91K-35.67%755.34K-34.86%1.31M-67.57%8.11M16.59%2.55M-46.22%2.38M-89.38%1.17M
Selling and administrative expenses -18.03%764.55K-31.35%3.05M-21.57%817.49K-60.36%564.71K-18.16%732.23K-13.41%932.71K-3.77%4.44M-5.82%1.04M15.09%1.42M-20.81%894.67K
-General and administrative expense -18.03%764.55K-31.35%3.05M-21.57%817.49K-60.36%564.71K-18.16%732.23K-13.41%932.71K-3.77%4.44M-5.82%1.04M15.09%1.42M-20.81%894.67K
Research and development costs 55.61%2.02M53.04%5.83M5.71%1.61M83.55%1.83M262.26%1.09M31.59%1.3M-82.24%3.81M14.02%1.52M-70.78%998.81K-97.06%300.3K
Other operating expenses -169.66%-2.49M-4,151.87%-5.89M-11,636.72%-1.83M-4,317.41%-2.07M-5,019.14%-1.06M-1,570.55%-922.58K86.97%-138.47K93.90%-15.6K80.19%-46.84K93.02%-20.8K
Operating profit 77.29%-297.1K72.19%-2.16M73.57%-585.76K106.29%149.49K64.40%-418.03K34.86%-1.31M67.07%-7.78M-1.32%-2.22M21.52%-2.38M89.38%-1.17M
Net non-operating interest income (expenses) -230.09%-1.23M-51.40%-1.61M13.81%-382.36K-64.60%-433.05K-122.63%-425.83K-121.71%-372.96K29.91%-1.07M61.27%-443.63K-11.42%-263.08K-45.74%-191.27K
Non-operating interest income --0-43.74%16.81K-91.50%562-40.34%5.58K-74.19%2.35K72.01%8.33K-11.41%29.88K20.83%6.61K36.98%9.35K84.02%9.09K
Non-operating interest expense 222.88%1.23M48.80%1.63M-14.95%382.92K61.00%438.62K113.71%428.18K120.32%381.29K-29.51%1.1M-60.88%450.24K12.14%272.43K47.12%200.36K
Other net income (expenses) -139.01%-56.71K118.01%65.66K-2,109.62%-126.39K152.20%137.31K68.52%-90.66K205.83%145.39K-741.72%-364.61K1,064.57%6.29K56.67%54.44K-2,032.45%-287.95K
Gain on sale of security -139.01%-56.71K118.01%65.66K-2,109.62%-126.39K152.20%137.31K68.52%-90.66K205.83%145.39K-741.72%-364.61K1,064.57%6.29K56.67%54.44K-2,032.45%-287.95K
Income before tax -3.18%-1.58M59.69%-3.71M58.76%-1.09M94.34%-146.25K43.48%-934.52K33.62%-1.54M63.29%-9.21M20.40%-2.65M19.96%-2.59M85.20%-1.65M
Income tax 091.20%69.58K30.28%8.96K-82.16%6.09K376.91%42.04K18.35%12.5K-5.37%36.39K1,764.65%6.88K268.09%34.13K-278.58%-15.18K
Earnings from equity interest net of tax
Net income -2.35%-1.58M59.09%-3.78M58.53%-1.1M94.18%-152.34K40.39%-976.56K33.39%-1.55M63.20%-9.24M20.18%-2.66M19.13%-2.62M85.34%-1.64M
Net income continuous operations -2.35%-1.58M59.09%-3.78M58.53%-1.1M94.18%-152.34K40.39%-976.56K33.39%-1.55M63.20%-9.24M20.18%-2.66M19.13%-2.62M85.34%-1.64M
Noncontrolling interests
Net income attributable to the company -2.35%-1.58M59.09%-3.78M58.53%-1.1M94.18%-152.34K40.39%-976.56K33.39%-1.55M63.20%-9.24M20.18%-2.66M19.13%-2.62M85.34%-1.64M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -2.35%-1.58M59.09%-3.78M58.53%-1.1M94.18%-152.34K40.39%-976.56K33.39%-1.55M63.20%-9.24M20.18%-2.66M19.13%-2.62M85.34%-1.64M
Diluted earnings per share 0.00%-0.0162.50%-0.0350.00%-0.0193.72%-0.00130.00%-0.0166.67%-0.0178.95%-0.0860.00%-0.0260.00%-0.0294.44%-0.01
Basic earnings per share 0.00%-0.0162.50%-0.0350.00%-0.0193.72%-0.00130.00%-0.0166.67%-0.0178.95%-0.0860.00%-0.0260.00%-0.0294.44%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data